Bayer Regorafenib Program
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/09/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts